MAP2 and Alzheimer disease: Among the genes associated with both AD and hypoglycemia, we have identified those that are promising for further study as drug targets (CCL2, CD40, CDKN1A, CYP3A4, FOS, HCRT, IGFBP2, IL6, MAP2, METAP2, NFE2L2, PARK7, SELP, SST, VEGFA and others).